SCHEMBL8154384

SCHEMBL8154384

CCC(CCOC)n1cc(-c2cc(C)c(OC)cc2C)nc1OC

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 3/20 0.36
SUV39H2 Q9H5I1 2/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8146626 0.91 CRHR1 (0.36) CRHR1SUV39H2TSHR
SCHEMBL8152497 0.90 CRHR1 (0.35) CRHR1SUV39H2
SCHEMBL8148200 0.88 TSHR (0.38) CRHR1SUV39H2TSHR
SCHEMBL8151719 0.81 CRHR1 (0.38) CRHR1
SCHEMBL8139794 0.80 CRHR1 (0.40) CRHR1SUV39H2
SCHEMBL8152915 0.78 CRHR1 (0.34) CRHR1SUV39H2TSHR
SCHEMBL8147374 0.78 CRHR1 (0.32) CRHR1
SCHEMBL8152412 0.78 CRHR1 (0.30) CRHR1
SCHEMBL8149046 0.78 TSHR (0.39) CRHR1TSHR
SCHEMBL8148157 0.77 CRHR1 (0.36) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed